Predicting Drug-Drug Interactions Using Heterogeneous Graph Neural Networks: HGNN-DDI
- URL: http://arxiv.org/abs/2508.18766v1
- Date: Tue, 26 Aug 2025 07:50:47 GMT
- Title: Predicting Drug-Drug Interactions Using Heterogeneous Graph Neural Networks: HGNN-DDI
- Authors: Hongbo Liu, Siyi Li, Zheng Yu,
- Abstract summary: Drug-drug interactions (DDIs) can lead to reduced therapeutic efficacy or severe adverse effects.<n>We propose HGNN-DDI, a graph neural network model designed to predict potential DDIs by integrating multiple drug-related data sources.<n> Experimental results on benchmark DDI datasets demonstrate that HGNN-DDI outperforms state-of-the-art baselines in prediction accuracy and robustness.
- Score: 8.48967497162918
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Drug-drug interactions (DDIs) are a major concern in clinical practice, as they can lead to reduced therapeutic efficacy or severe adverse effects. Traditional computational approaches often struggle to capture the complex relationships among drugs, targets, and biological entities. In this work, we propose HGNN-DDI, a heterogeneous graph neural network model designed to predict potential DDIs by integrating multiple drug-related data sources. HGNN-DDI leverages graph representation learning to model heterogeneous biomedical networks, enabling effective information propagation across diverse node and edge types. Experimental results on benchmark DDI datasets demonstrate that HGNN-DDI outperforms state-of-the-art baselines in prediction accuracy and robustness, highlighting its potential to support safer drug development and precision medicine.
Related papers
- KITE-DDI: A Knowledge graph Integrated Transformer Model for accurately predicting Drug-Drug Interaction Events from Drug SMILES and Biomedical Knowledge Graph [0.11049608786515838]
Drug-Drug Interactions (DDI) can cause significant bodily injury and even death.<n>Most contemporary research for predicting DDI events relies on either information from Biomedical Knowledge graphs (KG) or drug SMILES.<n>In this study, we propose a KG-integrated Transformer architecture to generate an end-to-end fully automated Machine Learning pipeline.
arXiv Detail & Related papers (2024-12-08T00:49:57Z) - Physical formula enhanced multi-task learning for pharmacokinetics prediction [54.13787789006417]
A major challenge for AI-driven drug discovery is the scarcity of high-quality data.
We develop a formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics simultaneously.
Our experiments reveal that PEMAL significantly lowers the data demand, compared to typical Graph Neural Networks.
arXiv Detail & Related papers (2024-04-16T07:42:55Z) - Learning to Describe for Predicting Zero-shot Drug-Drug Interactions [54.172575323610175]
Adverse drug-drug interactions can compromise the effectiveness of concurrent drug administration.
Traditional computational methods for DDI prediction may fail to capture interactions for new drugs due to the lack of knowledge.
We propose TextDDI with a language model-based DDI predictor and a reinforcement learning(RL)-based information selector.
arXiv Detail & Related papers (2024-03-13T09:42:46Z) - Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction.
BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner.
It maintains consistent and robust semantics by smoothing relations around the target interaction.
arXiv Detail & Related papers (2023-12-09T07:08:00Z) - Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning [39.66471292348325]
We present KnowDDI, a graph neural network-based method that addresses the challenge of discovering potential drug-drug interactions.
KnowDDI enhances drug representations by adaptively leveraging rich neighborhood information from large biomedical knowledge graphs.
As an original open-source tool, KnowDDI can help detect possible interactions in a broad range of relevant interaction prediction tasks.
arXiv Detail & Related papers (2023-11-25T15:44:28Z) - Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural
Network with Biomedical Network [69.16939798838159]
We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs.
EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths.
Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
arXiv Detail & Related papers (2023-11-15T06:34:00Z) - DDI Prediction via Heterogeneous Graph Attention Networks [0.0]
Polypharmacy is the use of multiple drugs together.
Drug-drug interaction (DDI) is the activity that occurs when the impact of one drug changes when combined with another.
We present a novel heterogeneous graph attention model, HAN-DDI, to predict drug-drug interactions.
arXiv Detail & Related papers (2022-07-12T16:59:06Z) - HyGNN: Drug-Drug Interaction Prediction via Hypergraph Neural Network [0.0]
Drug-Drug Interactions (DDIs) may hamper the functionalities of drugs, and in the worst scenario, they may lead to adverse drug reactions (ADRs)
This paper proposes a novel Hypergraph Neural Network (HyGNN) model based on only the SMILES string of drugs, available for any drug, for the DDI prediction problem.
Our proposed HyGNN model effectively predicts DDIs and impressively outperforms the baselines with a maximum ROC-AUC and PR-AUC of 97.9% and 98.1%, respectively.
arXiv Detail & Related papers (2022-06-25T22:48:27Z) - Multi-View Substructure Learning for Drug-Drug Interaction Prediction [69.34322811160912]
We propose a novel multi- view drug substructure network for DDI prediction (MSN-DDI)
MSN-DDI learns chemical substructures from both the representations of the single drug (intra-view) and the drug pair (inter-view) simultaneously and utilizes the substructures to update the drug representation iteratively.
Comprehensive evaluations demonstrate that MSN-DDI has almost solved DDI prediction for existing drugs by achieving a relatively improved accuracy of 19.32% and an over 99% accuracy under the transductive setting.
arXiv Detail & Related papers (2022-03-28T05:44:29Z) - AttentionDDI: Siamese Attention-based Deep Learning method for drug-drug
interaction predictions [0.9176056742068811]
Drug-drug interactions (DDIs) refer to processes triggered by the administration of two or more drugs leading to side effects beyond those observed when drugs are administered by themselves.
Due to the massive number of possible drug pairs, it is nearly impossible to experimentally test all combinations and discover previously unobserved side effects.
We propose a Siamese self-attention multi-modal neural network for DDI prediction that integrates multiple drug similarity measures.
arXiv Detail & Related papers (2020-12-24T13:33:07Z) - SumGNN: Multi-typed Drug Interaction Prediction via Efficient Knowledge
Graph Summarization [64.56399911605286]
We propose SumGNN: knowledge summarization graph neural network, which is enabled by a subgraph extraction module.
SumGNN outperforms the best baseline by up to 5.54%, and the performance gain is particularly significant in low data relation types.
arXiv Detail & Related papers (2020-10-04T00:14:57Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.